| 1. |
Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease. Lancet, 2022, 399(10342): 2227-2242.
|
| 2. |
Fiorentino G, Esquinas AM, Annunziata A. Exercise and chronic obstructive pulmonary disease (COPD). Adv Exp Med Biol, 2020, 1228: 355-368.
|
| 3. |
Moll G, Ankrum JA, Kamhieh-Milz J, et al. Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines. Trends Mol Med, 2019, 25(2): 149-163.
|
| 4. |
Sui BD, Zheng CX, Li M, et al. Epigenetic regulation of mesenchymal stem cell homeostasis. Trends Cell Biol, 2020, 30(2): 97-116.
|
| 5. |
Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science, 2020, 367(6478): eaau6977.
|
| 6. |
Hade MD, Suire CN, Suo Z. Mesenchymal stem cell-derived exosomes: applications in regenerative medicine. Cells, 2021, 10(8): 1959.
|
| 7. |
Abbaszadeh H, Ghorbani F, Abbaspour-Aghdam S, et al. Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools. Stem Cell Res Ther, 2022, 13(1): 262.
|
| 8. |
Zhai Z, Cui T, Chen J, et al. Advancements in engineered mesenchymal stem cell exosomes for chronic lung disease treatment. J Transl Med, 2023, 21(1): 895.
|
| 9. |
Stockley RA, Halpin DMG, Celli BR, et al. Chronic obstructive pulmonary disease biomarkers and their interpretation. Am J Respir Crit Care Med, 2019, 199(10): 1195-1204.
|
| 10. |
Zhang Y, Fei X, Zhang X, et al. Adipose-derived mesenchymal stem cells suppress ozone-mediated airway inflammation in a mouse model of chronic obstructive pulmonary disease. Mol Immunol, 2022, 151: 95-102.
|
| 11. |
Chen YT, Miao K, Zhou L, et al. Stem cell therapy for chronic obstructive pulmonary disease. Chin Med J (Engl), 2021, 134(13): 1535-1545.
|
| 12. |
Baranasic J, Niazi Y, Chattopadhyay S, et al. Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development. Acta Pharm (Zagreb), 2023, 73(2): 243-256.
|
| 13. |
Jeffries J, Zhou W, Hsu AY, et al. miRNA-223 at the crossroads of inflammation and cancer. Cancer Lett, 2019, 451: 136-141.
|
| 14. |
Abarca-Merlin DM, Martínez-Durán JA, Medina-Pérez JD, et al. From immunity to neurogenesis: Toll-like receptors as versatile regulators in the nervous system. Int J Mol Sci, 2024, 25(11): 5711.
|
| 15. |
Hezam K, Wang C, Fu E, et al. Superior protective effects of PGE2 priming mesenchymal stem cells against LPS-induced acute lung injury (ALI) through macrophage immunomodulation. Stem Cell Res Ther, 2023, 14(1): 48.
|
| 16. |
Su G, Ma X, Wei H. Multiple biological roles of extracellular vesicles in lung injury and inflammation microenvironment. Biomed Res Int, 2020, 2020: 5608382.
|
| 17. |
Wang C, Jiang C, Yang Y, et al. Therapeutic potential of HUC-MSC-exos primed with IFN-γ against LPS-induced acute lung injury. Iran J Basic Med Sci, 2024, 27(3): 375-382.
|
| 18. |
Ma B, Hottiger MO. Crosstalk between Wnt/β-Catenin and NF-κB signaling pathway during inflammation. Front Immunol, 2016, 7: 378.
|
| 19. |
Yi X, Wei X, Lv H, et al. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Exp Cell Res, 2019, 383(2): 111454.
|
| 20. |
Michaeloudes C, Li X, Mak JCW, et al. Study of mesenchymal stem cell-mediated mitochondrial transfer in in vitro models of oxidant-mediated airway epithelial and smooth muscle cell injury. Methods Mol Biol, 2021, 2269: 93-105.
|
| 21. |
Liu S, Tan X, Liu S. The role of extracellular vesicles in COPD and potential clinical value. Respir Res, 2024, 25(1): 84.
|
| 22. |
Mukkala AN, Jerkic M, Khan Z, et al. Therapeutic effects of mesenchymal stromal cells require mitochondrial transfer and quality control. Int J Mol Sci, 2023, 24(21): 15788.
|
| 23. |
宋慶, 林鈴, 李雪杉, 等. 慢性阻塞性肺疾病與干細胞的研究進展. 中國呼吸與危重監護雜志, 2022, 21(10): 745-750.
|
| 24. |
Lettieri S, Bertuccio FR, Del Frate L, et al. The plastic interplay between lung regeneration phenomena and fibrotic evolution: current challenges and novel therapeutic perspectives. Int J Mol Sci, 2023, 25(1): 547.
|
| 25. |
Kruk DMLW, Wisman M, Noordhoek JA, et al. Paracrine regulation of alveolar epithelial damage and repair responses by human lung-resident mesenchymal stromal cells. cells, 2021, 10(11): 2860.
|
| 26. |
Kruk DMLW, Wisman M, Bruin HG, et al. Abnormalities in reparative function of lung-derived mesenchymal stromal cells in emphysema. Am J Physiol Lung Cell Mol Physiol, 2021, 320(5): L832-L844.
|
| 27. |
Chong L, Ahmadvand N, Noori A, et al. Injury activated alveolar progenitors (IAAPs): the underdog of lung repair. Cell Mol Life Sci, 2023, 80(6): 145.
|
| 28. |
Rabata A, Fedr R, Soucek K, et al. 3D cell culture models demonstrate a role for FGF and WNT signaling in regulation of lung epithelial cell fate and morphogenesis. Front Cell Dev Biol, 2020, 8: 574.
|
| 29. |
Yuan D, Bao Y, El-Hashash A. Mesenchymal stromal cell-based therapy in lung diseases; from research to clinic. Am J Stem Cells, 2024, 13(2): 37-58.
|
| 30. |
Guo H, Su Y, Deng F. Effects of mesenchymal stromal cell-derived extracellular vesicles in lung diseases: current status and future perspectives. Stem Cell Rev Rep, 2021, 17(2): 440-458.
|
| 31. |
Harrell CR, Miloradovic D, Sadikot R, et al. Molecular and cellular mechanisms responsible for beneficial effects of mesenchymal stem cell-derived product "Exo-d-MAPPS" in attenuation of chronic airway inflammation. Anal Cell Pathol (Amst), 2020, 2020: 3153891.
|
| 32. |
Chen Q, Lin J, Deng Z, et al. Exosomes derived from human umbilical cord mesenchymal stem cells protect against papain-induced emphysema by preventing apoptosis through activating VEGF-VEGFR2-mediated AKT and MEK/ERK pathways in rats. Regen Ther, 2022, 21: 216-224.
|
| 33. |
Joel MDM, Yuan J, Wang J, et al. MSC: immunoregulatory effects, roles on neutrophils and evolving clinical potentials. Am J Transl Res, 2019, 11(6): 3890-3904.
|
| 34. |
Harrell CR, Djonov V, Volarevic V. The cross-talk between mesenchymal stem cells and immune cells in tissue repair and regeneration. Int J Mol Sci, 2021, 22(5): 2472.
|
| 35. |
Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci, 2020, 41(9): 653-664.
|
| 36. |
Meng M, Zhang WW, Chen SF, et al. Therapeutic utility of human umbilical cord-derived mesenchymal stem cells-based approaches in pulmonary diseases: Recent advancements and prospects. World J Stem Cells, 2024, 16(2): 70-88.
|
| 37. |
Strizova Z, Benesova I, Bartolini R, et al. M1/M2 macrophages and their overlaps - myth or reality? Clin Sci (Lond), 2023, 137(15): 1067-1093.
|
| 38. |
Broekman W, Amatngalim GD, de Mooij-Eijk Y, et al. TNF-α and IL-1β-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor. Respir Res, 2016, 17: 3.
|
| 39. |
Guarnier LP, Moro LG, Lívero FADR, et al. Regenerative and translational medicine in COPD: hype and hope. Eur Respir Rev, 2023, 32(169): 220223.
|
| 40. |
Chen L, Qu J, Kalyani FS, et al. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications. Cell Mol Life Sci, 2022, 79(3): 142.
|
| 41. |
Qian X, An N, Ren Y, et al. Immunosuppressive effects of mesenchymal stem cells-derived exosomes. Stem Cell Rev Rep, 2021, 17(2): 411-427.
|
| 42. |
Song Y, Dou H, Li X, et al. Exosomal miR-146a Contributes to the enhanced therapeutic efficacy of interleukin-1β-primed mesenchymal stem cells against sepsis. Stem Cells, 2017, 35(5): 1208-1221.
|
